| Drug Name |
Ospemifene |
| Drug ID |
BADD_D01630 |
| Description |
Ospemifene is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. FDA approved on February 26, 2013. |
| Indications and Usage |
Ospemifene is used for the treatment of moderate to dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. |
| Marketing Status |
approved; investigational |
| ATC Code |
G03XC05 |
| DrugBank ID |
DB04938
|
| KEGG ID |
D08958
|
| MeSH ID |
C119141
|
| PubChem ID |
3036505
|
| TTD Drug ID |
D02CTS
|
| NDC Product Code |
69037-0026; 55494-580; 63069-601; 59630-580; 50056-2021; 66039-912 |
| UNII |
B0P231ILBK
|
| Synonyms |
Ospemifene | Z-2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol | Osphena | Senshio | FC-1271a |
